← All companies

DRUG

Bright Minds Biosciences Inc.

DRUG Nasdaq Pharmaceutical Preparations EDGAR ↗

$73.78

-0.85 -1.14%

Key statistics

from XBRL data in SEC filings

Market cap

$334M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$32.50 – $123.75

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jun 3, 2026 6-K FORM 6-K Jun 2, 2026 6-K May 28, 2026 6-K FORM 6-K May 20, 2026 6-K FORM 6-K Feb 13, 2026 6-K FORM 6-K Jan 9, 2026 6-K FORM 6-K Jan 9, 2026 6-K Jan 8, 2026 6-K FORM 6-K Jan 7, 2026 6-K Jan 7, 2026 6-K Jan 6, 2026 6-K Jan 5, 2026 40-F FORM 40-F Dec 23, 2025 6-K FORM 6-K Nov 17, 2025 6-K/A FORM 6-K/A Nov 17, 2025 6-K FORM 6-K Nov 7, 2025 6-K FORM 6-K Nov 7, 2025 6-K Sep 5, 2025 6-K FORM 6-K Aug 15, 2025 6-K FORM 6-K Aug 11, 2025 6-K May 28, 2025 6-K May 21, 2025 6-K May 14, 2025 6-K Apr 29, 2025 6-K Mar 5, 2025 6-K Feb 24, 2025 6-K FORM 6-K Feb 14, 2025 6-K Jan 8, 2025 20-F FORM 20-F Dec 31, 2024 6-K FORM 6-K Nov 21, 2024 6-K FORM 6-K Nov 5, 2024 6-K Oct 21, 2024 6-K Oct 18, 2024 6-K Oct 16, 2024 6-K FORM 6-K Oct 16, 2024 6-K FORM 6-K Oct 3, 2024 6-K Sep 12, 2024 6-K FORM 6-K Aug 15, 2024 6-K FORM 6-K May 17, 2024 6-K FORM 6-K May 17, 2024